282 related articles for article (PubMed ID: 25783795)
41. Prognostic scores for patients with chronic myeloid leukemia under particular consideration of competing causes of death.
Pfirrmann M; Lauseker M; Hoffmann VS; Hasford J
Ann Hematol; 2015 Apr; 94 Suppl 2():S209-18. PubMed ID: 25814087
[TBL] [Abstract][Full Text] [Related]
42. Chronic myelogenous leukemia in eastern Pennsylvania: an assessment of registry reporting.
Mertz KJ; Buchanich JM; Washington TL; Irvin-Barnwell EA; Woytowitz DV; Smith RE
J Registry Manag; 2015; 42(1):9-11. PubMed ID: 25961786
[TBL] [Abstract][Full Text] [Related]
43. [A clinical and laboratory study of chronic myeloid leukemia with atypical BCR-ABL fusion gene subtypes].
Gui X; Pan J; Qiu H; Cen J; Xue Y; Chen S; Shen H; Yao L; Zhang J; Wu Y; Chen Y
Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):210-4. PubMed ID: 24666486
[TBL] [Abstract][Full Text] [Related]
44. [Detection of phosphotyrosine in chronic myeloid leukemia cells with PY20 antibody and its clinical applications].
Tian J; Cheng H; Xu KL; Pan XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):1056-60. PubMed ID: 19698259
[TBL] [Abstract][Full Text] [Related]
45. BCR-ABL1 mutations in patients with imatinib-resistant Philadelphia chromosome-positive leukemia by use of the PCR-Invader assay.
Ono T; Miyawaki S; Kimura F; Kanamori H; Ohtake S; Kitamura K; Fujita H; Sugiura I; Usuki K; Emi N; Tamaki S; Aoyama Y; Kaya H; Naoe T; Tadokoro K; Yamaguchi T; Ohno R; Ohnishi K;
Leuk Res; 2011 May; 35(5):598-603. PubMed ID: 21239056
[TBL] [Abstract][Full Text] [Related]
46. Profile of BCR-ABL transcript levels based on Sokal prognostic score in chronic myeloid leukemia patients treated with imatinib.
Ashariati A; Ugroseno S
Acta Med Indones; 2013 Apr; 45(2):107-13. PubMed ID: 23770790
[TBL] [Abstract][Full Text] [Related]
47. Increased prevalence of prior malignancies and autoimmune diseases in patients diagnosed with chronic myeloid leukemia.
Gunnarsson N; Höglund M; Stenke L; Wållberg-Jonsson S; Sandin F; Björkholm M; Dreimane A; Lambe M; Markevärn B; Olsson-Strömberg U; Wadenvik H; Richter J; Själander A
Leukemia; 2016 Jul; 30(7):1562-7. PubMed ID: 27080811
[TBL] [Abstract][Full Text] [Related]
48. A significant proportion of patients with chronic myeloid leukemia and suboptimal response according to European Leukemia Net criteria have excellent prognosis without treatment change.
Rohon P; Faber E; Divoka M; Rozmanova S; Friedecky D; Jarosova M; Indrak K
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Jun; 157(2):181-8. PubMed ID: 22660209
[TBL] [Abstract][Full Text] [Related]
49. Endogenous erythroid colony formation in chronic myeloid leukemia: a recurrent finding associated with persistent minimal residual disease under imatinib.
Einwallner E; Jaeger E; Mitterbauer-Hohendanner G; Bilban M; Simonitsch-Klupp I; Steiner I; Pernicka E; Hoermann G; Herndlhofer S; Sillaber C; Valent P; Schwarzinger I
Stem Cells Dev; 2013 Dec; 22(23):3043-51. PubMed ID: 23883175
[TBL] [Abstract][Full Text] [Related]
50. High-dose hydroxyurea plus G-CSF mobilize BCR-ABL-negative progenitor cells (CFC, LTC-IC) into the blood of newly diagnosed CML patients at any time of hematopoietic regeneration.
Petzer AL; Hochenburger E; Haun M; Duba HCh; Grünewald K; Hoflehner E; Sill H; Linkesch W; Gastl G; Gunsilius E
J Hematother Stem Cell Res; 2002 Apr; 11(2):293-300. PubMed ID: 11983100
[TBL] [Abstract][Full Text] [Related]
51. U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval.
Cohen MH; Johnson JR; Pazdur R
Clin Cancer Res; 2005 Jan; 11(1):12-9. PubMed ID: 15671523
[TBL] [Abstract][Full Text] [Related]
52. [STI 571 for treating 19 patients with chronic-phase chronic myeloid leukemia].
Meng FY; Zheng WY; Liu XL; Xu B; Song LL; Zhang Y; Huang F
Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1149-50. PubMed ID: 14625174
[TBL] [Abstract][Full Text] [Related]
53. Are chronic myeloid leukemia patients more at risk for second malignancies? A population-based study.
Rebora P; Czene K; Antolini L; Gambacorti Passerini C; Reilly M; Valsecchi MG
Am J Epidemiol; 2010 Nov; 172(9):1028-33. PubMed ID: 20861143
[TBL] [Abstract][Full Text] [Related]
54. Estimation of CML incidence: disagreement between national cancer registry and health claims data system in Taiwan.
Chang CS; Lee K; Yang YH; Lin MT; Hsu CN
Leuk Res; 2011 May; 35(5):e53-4. PubMed ID: 21255835
[No Abstract] [Full Text] [Related]
55. Effects of age on prognosis with imatinib mesylate therapy for patients with Philadelphia chromosome-positive chronic myelogenous leukemia.
Cortes J; Talpaz M; O'Brien S; Giles F; Beth Rios M; Shan J; Faderl S; Garcia-Manero G; Ferrajoli A; Wierda W; Kantarjian H
Cancer; 2003 Sep; 98(6):1105-13. PubMed ID: 12973833
[TBL] [Abstract][Full Text] [Related]
56. Long-term safety and efficacy of imatinib mesylate (Gleevec®) in elderly patients with chronic phase chronic myelogenous leukemia: results of the AFR04 study.
Rousselot P; Cony-Makhoul P; Nicolini F; Mahon FX; Berthou C; Réa D; Reiffers J; Bornand A; Saint-Jean O; Guilhot J; Guilhot F;
Am J Hematol; 2013 Jan; 88(1):1-4. PubMed ID: 22987312
[TBL] [Abstract][Full Text] [Related]
57. Dasatinib first-line: Multicentric Italian experience outside clinical trials.
Breccia M; Stagno F; Luciano L; Abruzzese E; Annunziata M; D'Adda M; Maggi A; Sgherza N; Russo-Rossi A; Pregno P; Castagnetti F; Iurlo A; Latagliata R; Cedrone M; Di Renzo N; Sorà F; Rege-Cambrin G; La Nasa G; Scortechini AR; Greco G; Franceschini L; Sica S; Bocchia M; Crugnola M; Orlandi E; Guarini A; Specchia G; Rosti G; Saglio G; Alimena G
Leuk Res; 2016 Jan; 40():24-9. PubMed ID: 26643920
[TBL] [Abstract][Full Text] [Related]
58. Treatment of Philadelphia chromosome-positive early chronic phase chronic myelogenous leukemia with daily doses of interferon alpha and low-dose cytarabine.
Kantarjian HM; O'Brien S; Smith TL; Rios MB; Cortes J; Beran M; Koller C; Giles FJ; Andreeff M; Kornblau S; Giralt S; Keating MJ; Talpaz M
J Clin Oncol; 1999 Jan; 17(1):284-92. PubMed ID: 10458244
[TBL] [Abstract][Full Text] [Related]
59. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
60. [Clinical epidemiology].
Ohyashiki K
Nihon Rinsho; 2001 Dec; 59(12):2416-20. PubMed ID: 11766349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
